News
Smoking, air pollution and several other factors have led to significant disparities in lung health across the U.S.
Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...
New study results with GSK's anti-IL-5 antibody Nucala in chronic obstructive pulmonary disease (COPD) have been published, just ahead of an FDA decision on the new indication scheduled for 7th ...
Biologics A high eosinophil count in your blood can contribute to COPD. Dupixent (dupilumab) and Nucala (mepolizumab) are biologic medications made from living cells, rather than synthetic chemicals.
Background This study aimed to evaluate whether incidental CT findings of emphysema, airway thickening and bronchiectasis, as seen on CT scans performed for other non-pulmonary clinical indications, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results